Indonesia Vaccine Market Report by Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), and Region 2024-2032

Indonesia Vaccine Market Report by Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A16872
Buy Now

Market Overview:

The Indonesia vaccine market size is projected to exhibit a growth rate (CAGR) of 6.26% during 2024-2032. The rising demand for immunization against infectious diseases, the implementation of various government initiatives, growing focus on achieving the sustainable development goals pertaining to health, increasing research and development (R&D) activities, and the heightened collaborations between government bodies and vaccine manufacturers represent some of the key factors driving the market.

Report Attribute
Key Statistics
Base Year
2023
Forecast Years
2024-2032
Historical Years
2018-2023
Market Growth Rate (2024-2032) 6.26%


Vaccines refer to biologically prepared agents that resemble disease-causing microorganisms, designed to stimulate the body's immune response without causing the actual disease. They are primarily composed of weakened or killed forms of microbes, their toxins, or one of their surface proteins. Vaccines are available in various types, including live attenuated, inactivated, subunit, toxoid, conjugate, and messenger ribonucleic acid (mRNA) vaccines, each with unique properties and methods of preparation. They are developed using various antigenic elements, adjuvants, preservatives, and stabilizers. Vaccines are widely utilized in preventing multiple diseases, such as measles, influenza, polio, tetanus, diphtheria, hepatitis, coronavirus (COVID-19), and human papillomavirus (HPV). They contribute to the eradication of infectious diseases, safeguard vulnerable populations, support the health of travelers, and enable pandemic responses. Vaccines also offer numerous benefits, including death prevention, global health security, longevity, and enhanced quality of life. Moreover, they provide cost-effectiveness, foster herd immunity, reduce antimicrobial resistance, and advance public health initiatives.

Indonesia Vaccine Market Trends:

The increasing utilization of vaccines due to a rising demand for immunization against infectious diseases is one of the major factors contributing to the market growth. Along with this, the introduction of various government initiatives to improve healthcare access and the introduction of the national immunization program are providing a thrust to the market growth. Besides this, the rising government focus on achieving the sustainable development goals pertaining to health, prompting proactive steps in expanding its vaccination coverage, is favoring the market growth. Additionally, the heightened awareness of vaccine-preventable diseases, fueled by public health campaigns and the endorsement of vaccinations by medical professionals, is creating a positive outlook for the market growth. Furthermore, the growing incidence of diseases, such as dengue fever, tuberculosis, and hepatitis, necessitating a steady supply of vaccines, is driving the market growth. In addition to this, the increasing research and development (R&D) activities by pharmaceutical companies to develop advanced vaccination formulations are boosting the market growth. Apart from this, the heightened collaborations between government bodies and vaccine manufacturers, resulting in the introduction of advanced vaccines with better efficacy and safety profiles, are providing an impetus to the market growth. Moreover, the development of healthcare infrastructure, cold chain systems, and storage facilities in Indonesia, enhancing the distribution and availability of vaccines across the country, is catalyzing the market growth. Besides this, the increasing partnerships among the Indonesian government and global health organizations supporting vaccine procurement and distribution efforts are acting as a growth-inducing factor. Furthermore, the introduction of health insurance coverage and reimbursement policies for vaccinations, making them more accessible to a larger segment of the population, is offering remunerative growth opportunities for the market across the country.

Indonesia Vaccine Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the country level for 2024-2032. Our report has categorized the market based on product type, treatment type, technology, route of administration, patient type, indication, distribution channel, and end user.

Product Type Insights:

  • Multivalent Vaccine
  • Monovalent Vaccine
     

The report has provided a detailed breakup and analysis of the market based on the product type. This includes multivalent vaccine and monovalent vaccine.

Treatment Type Insights:

  • Preventive Vaccine
  • Therapeutic Vaccine
     

A detailed breakup and analysis of the market based on the treatment type have also been provided in the report. This includes preventive vaccine and therapeutic vaccine.

Technology Insights:

  • Conjugate Vaccines
  • Inactivated and Subunit Vaccines
  • Live Attenuated Vaccines
  • Recombinant Vaccines
  • Toxoid Vaccines
  • Others
     

The report has provided a detailed breakup and analysis of the market based on the technology. This includes conjugate vaccines, inactivated and subunit vaccines, live attenuated vaccines, recombinant vaccines, toxoid vaccines, and others.

Route of Administration Insights:

  • Intramuscular and Subcutaneous Administration
  • Oral Administration
  • Others
     

A detailed breakup and analysis of the market based on the route of administration have also been provided in the report. This includes intramuscular and subcutaneous administration, oral administration, and others.

Patient Type Insights:

  • Pediatric
  • Adult
     

The report has provided a detailed breakup and analysis of the market based on patient type. This includes pediatric and adult.

Indication Insights:

  • Bacterial Diseases
    • Meningococcal Disease
    • Pneumococcal Disease
    • Diphtheria/Tetanus/Pertussis (DPT)
    • Tuberculosis
    • Haemophilus Influenzae (Hib)
    • Typhoid
    • Others
  • Viral Diseases
    • Hepatitis
    • Influenza
    • Human Papillomavirus (HPV)
    • Measles/Mumps/Rubella (MMR)
    • Rotavirus
    • Herpes Zoster
    • Varicella
    • Japanese Encephalitis
    • Rubella
    • Polio
    • Rabies
    • Dengue
    • Others
       

A detailed breakup and analysis of the market based on the indication have also been provided in the report. This includes bacterial diseases (meningococcal disease, pneumococcal disease, diphtheria/tetanus/pertussis (DPT), tuberculosis, haemophilus influenzae (Hib), typhoid, and others) and viral diseases (hepatitis, influenza, human papillomavirus (HPV), measles/mumps/rubella (MMR), rotavirus, herpes zoster, varicella, Japanese encephalitis, rubella, polio, rabies, dengue, and others).

Distribution Channel Insights:

  • Hospital Pharmacies
  • Retail Pharmacies
  • Institutional Sales
  • Others
     

The report has provided a detailed breakup and analysis of the market based on distribution channel. This includes hospital pharmacies, retail pharmacies, institutional sales, and others.

End User Insights:

  • Hospitals
  • Clinics
  • Vaccination Centers
  • Academic and Research Institutes
  • Others
     

A detailed breakup and analysis of the market based on the end user have also been provided in the report. This includes hospitals, clinics, vaccination centers, academic and research institutes, and others.

Regional Insights:

  • Java
  • Sumatra
  • Kalimantan
  • Sulawesi
  • Others
     

The report has also provided a comprehensive analysis of all the major regional markets, which include Java, Sumatra, Kalimantan, Sulawesi, and Others.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.

Indonesia Vaccine Market Report Coverage:

Report Features Details
Base Year of the Analysis 2023
 Historical Period 2018-2023
Forecast Period 2024-2032
Units US$ Million
Scope of the Report Exploration of Historical Trends and Market Outlook, Industry Catalysts and Challenges, Segment-Wise Historical and Future Market Assessment:
  • Product Type
  • Treatment Type
  • Technology
  • Route of Administration
  • Patient Type
  • Indication
  • Distribution Channel
  • End User
  • Region
Product Types Covered Multivalent Vaccine, Monovalent Vaccine
Treatment Types Covered Preventive Vaccine, Therapeutic Vaccine
Technologies Covered Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, Others
Route of Administrations Covered Intramuscular and Subcutaneous Administration, Oral Administration, Others
Patient Types Covered Pediatric, Adult
Indications Covered
  • Bacterial Diseases: Meningococcal Disease, Pneumococcal Disease, Diphtheria/Tetanus/Pertussis (DPT), Tuberculosis, Haemophilus Influenzae (Hib), Typhoid, Others
  • Viral Diseases: Hepatitis, Influenza, Human Papillomavirus (HPV), Measles/Mumps/Rubella (MMR), Rotavirus, Herpes Zoster, Varicella, Japanese Encephalitis, Rubella, Polio, Rabies, Dengue, Others
Distribution Channels Covered Hospital Pharmacies, Retail Pharmacies, Institutional Sales, Others
End Users Covered Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, Others
Regions Covered Java, Sumatra, Kalimantan, Sulawesi, Others
Customization Scope 10% Free Customization
Report Price and Purchase Option Single User License: US$ 3699
Five User License: US$ 4699
Corporate License: US$ 5699
Post-Sale Analyst Support 10-12 Weeks
Delivery Format PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)

Key Questions Answered in This Report:

  • How has the Indonesia vaccine market performed so far and how will it perform in the coming years?
  • What has been the impact of COVID-19 on the Indonesia vaccine market?
  • What is the breakup of the Indonesia vaccine market on the basis of product type?
  • What is the breakup of the Indonesia vaccine market on the basis of treatment type?
  • What is the breakup of the Indonesia vaccine market on the basis of technology?
  • What is the breakup of the Indonesia vaccine market on the basis of route of administration?
  • What is the breakup of the Indonesia vaccine market on the basis of patient type?
  • What is the breakup of the Indonesia vaccine market on the basis of indication?
  • What is the breakup of the Indonesia vaccine market on the basis of distribution channel?
  • What is the breakup of the Indonesia vaccine market on the basis of end user?
  • What are the various stages in the value chain of the Indonesia vaccine market? 
  • What are the key driving factors and challenges in the Indonesia vaccine?
  • What is the structure of the Indonesia vaccine market and who are the key players?
  • What is the degree of competition in the Indonesia vaccine market? 

Key Benefits for Stakeholders:

  • IMARC’s industry report offers a comprehensive quantitative analysis of various market segments, historical and current market trends, market forecasts, and dynamics of the Indonesia vaccine market from 2018-2032.
  • The research report provides the latest information on the market drivers, challenges, and opportunities in the Indonesia vaccine market.
  • Porter's five forces analysis assist stakeholders in assessing the impact of new entrants, competitive rivalry, supplier power, buyer power, and the threat of substitution. It helps stakeholders to analyze the level of competition within the Indonesia vaccine industry and its attractiveness.
  • Competitive landscape allows stakeholders to understand their competitive environment and provides an insight into the current positions of key players in the market.

Need more help?

  • Speak to our experienced analysts for insights on the current market scenarios.
  • Include additional segments and countries to customize the report as per your requirement.
  • Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
  • For further assistance, please connect with our analysts.
Indonesia Vaccine Market Report by Product Type (Multivalent Vaccine, Monovalent Vaccine), Treatment Type (Preventive Vaccine, Therapeutic Vaccine), Technology (Conjugate Vaccines, Inactivated and Subunit Vaccines, Live Attenuated Vaccines, Recombinant Vaccines, Toxoid Vaccines, and Others), Route of Administration (Intramuscular and Subcutaneous Administration, Oral Administration, and Others), Patient Type (Pediatric, Adult), Indication (Bacterial Diseases, Viral Diseases), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Institutional Sales, and Others), End User (Hospitals, Clinics, Vaccination Centers, Academic and Research Institutes, and Others), and Region 2024-2032
Purchase options




Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More